Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 215-221

  Chiu, Jason J ^a,b   Sgagias, Magdalene K ^b   Cowan, Kenneth H ^b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GROWTH FACTOR; INTERLEUKIN 6;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; BREAST NEOPLASMS; FEMALE; GROWTH SUBSTANCES; HUMANS; INTERLEUKIN-6; RECEPTORS, ESTROGEN; RECEPTORS, INTERLEUKIN-6; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0030034383     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kishimoto, T. The biology of interleukin 6. Blood, 74: 1-10, 1989.
2. Gauldie, J., Richards, C., Harnish, D., Landrop, P., and Baumann, H. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase response in liver cells. Proc. Natl. Acad. Sci. USA, 84: 7251-7255, 1987.
3. Spangelo, B. L., Judd, A. M., Isakson, P. C., and McLeod, R. M. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology, 125: 575-577, 1989.
4. Hirano, T., Taga, Y., Nakano, N., Yasukawa, L., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K. H , and Kishimoto, T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc. Natl. Acad. Sci. USA, 82, 5490-5494, 1985.
5. Shabo, Y., Lotem, J., Rubinstein, M., Revel, M., Clark, S. C , Wolf, S. F., Kamen, R., and Sachs, L. The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood, 72: 2070-2073, 1988.
6. Shabo, Y., Lotem, J., and Sachs, L. Autoregulation of interleukin 6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemic cells. Mol. Cell. Biol., 9: 4109-4112, 1989.
7. Kawano, M., Hirano, T., Matsuda, T , Horii, Y., Iwato, K., Asaoku, H., Tang, B , Tanabe, O., Tanaka, H., Kuramoto, A., and Kishimoto, T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature (Lond.), 332: 83-85, 1988.
8. Van Damme, J., Opdenakker, G., Simpson, R J , Rubira, M R., Cayphas, S., Vink, A., Biliau, A., and Van Snick, J. Identification of the human 26-Kd protein interferon-β2 as a B cell hybridoma/plasmacytoma growth factor induced by interleukin-1 and tumor necrosis factor. J. Exp. Med., 165: 914-919, 1987.
9. Jilka, R. L , Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., and Manolagas, S. C. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (Washington DC), 257: 88-91, 1992.
10. 2. Proc. Natl. Acad. Sci. USA, 5: 8037-8041, 1988
11. Danforth, D. N., and Sgagias, M. K. Interleukin-1α and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res., 53: 1538-1545, 1993.
12. Krueger, J., Ray, A., Tam, I., and Sehgal, P. B. Expression and function of interleukin-6 in epithelial cells. J. Cell Biochem , 45: 327-334, 1991.
13. Basolo, F , Calvo, S., Fiore, L., Conaldi, P. G., Falcone, V., and Toniolo, A. Growth-stimulatory activity of interleukin-6 on human mammary epithelial cells transfected with the int-2 gene. Cancer Res., 53: 2957-2960, 1993.
14. Hirano, T., Akira, S., Taga, T., and Kishimoto, T. Biological and clinical aspects of interleukin-6. Immunol. Today, 11: 443-449, 1990
15. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., and Kishimoto, T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell, 63: 1149-1157, 1990.
16. Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., and Kishimoto, T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell, 58: 573-581, 1989.
17. Yasukawa, K., Saito, T., Fukunaga, T., Sekimori, Y., Koishiarar, Y., Fukui, H., Ohsugi, Y., Matsuda, T., Yawata, H., Hirano, Y., Taga, T., and Kishimoto, T. Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J. Biochem., 108: 673-676, 1990.
18. Chen, L., Shulman, L. M., and Revel, M. IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells. J. Biol. Regul. Homeostatic Agents, 5: 125-136, 1991.
19. Hirata, Y., Taga, T., Hibi, M., Nakano, N., Hirano, T., and Kishimoto, T. Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J. Immunol., 143: 2900-2906, 1989.
20. Maniatis, T., Fritsch, E. F., and Sambrook, J. Extraction, purification and analysis of mRNA from eukaryotic cells. In: Molecular Cloning: A Laboratory Manual, Vol. 1, pp. 7.23-7.29. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
21. Tamm, I., Cardinale, I., Krueger, J., Murphy, J. S., May, L. T., and Sehgal, P. B. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J. Exp. Med., 170: 1649-1669, 1989.
22. Watson, J. M., Sensintaffar, J. L., Berek, J. S., and Martinez-Maza, O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res., 50: 6959-6965, 1990.
23. Takenawa, J., Kaneko, Y., Fukumoto, M., Hirano, T., Fukuyama, H., Nakayama, H., Fujita, J., and Ostuda, O. Enhanced expression of interleukin-6 in primary human renal cell carcinoma. J. Natl. Cancer Inst., 83: 1668-1672, 1991.
24. Siegall, C. B., Schwab, G., Nordan, R. P., FitzGerald, D. J., and Pastan, I. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res., 50: 7786-7788, 1990.
25. Adams, E. F., Rafferty, B., and White, M. C Interleukin 6 is secreted by breast fibroblasts and stimulates 17β-estradiol exidoreductase activity of MCF-7 cells: possible paracrine regulation of breast 17β-estradiol levels. Int. J. Cancer, 49. 118-121, 1991.
26. Hutchins, D., and Steel, C. M. Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors. Int. J. Cancer., 58: 80-84, 1994.
27. Miki, S., Iswano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Sonoda, T., Hirano, T., and Kishimoto, T. Interleukin 6 functions as an in vitro autocrine growth factor in renal cell carcinoma. FEBS Lett., 250: 607-610, 1989.
28. Miles, S. A., Rezai, A. R., Salazar-Gonzalez, J. F., Meyden, M. V., Stevens, R. H., Logan, D. M., Mitsuyasu, R. T., Taga, T., Hirano, T., Kishimoto, T., and Martinez-Maza O. AIDS-Kaposi's sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. USA, 40: 4068-4072, 1990.
29. Akira, S., and Kishimoto, T. The evidence for interleukin-6 as an autocrine growth factor in malignancy. Semin. Cancer Biol., 3: 17-26, 1992.
30. Lopez, M., Maroc, N., Kerangueven, F., Bardin, F., Courcoul, M., Lavezzi, C., Birg, F., and Mannoni, P. Coexpression of the genes for interleukin 6 and its receptor without apparent involvement in the proliferation of acute myeloid leukemia cells. Exp. Hematol., 19: 797-803, 1991.
31. Tabibzadeh, S. S., Poubouridis, D., May, L. T., and Sehgal, P. B. Interleukin 6 immunoreactivity in human tumors. Am. J. Pathol., 135: 4068-4072, 1989.
32. Kerbel, R. S. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv. Cancer Res., 55: 87-132, 1990.
33. Verhasselt, B., Van Damme, J., VanLarebeke, N., Put, W., Bracke, M., De Potter, C., and Mareel, M. Interleukin-1 is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6. Eur. J. Cell Biol., 59: 449-457, 1992.
34. Kishimoto, T., Akira, S., and Taga, T. Interleukin-6 and its receptor: a paradigm for cytokines. Science (Washington DC), 258: 593-597, 1992.
35. Tanigawa, T., Elwood, N., Metcalf, D., Cary, D., DeLuca, E., Nicola, N. A., and Begley, C. G. The SCL gene is regulated by and differentially regulates cytokine responses during myeloid cell differentiation. Proc. Natl. Acad. Sci. USA, 90: 7864-7868, 1993
36. Gudas, J. M., Hoang, H., Klein, R. C., Katayose, D., Seth, P., and Cowan, K. H. Differential expression of multiple mdm2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Clin. Cancer Res., 1: 71-80,1995
37. Guerin, M , Sheng, Z. M., Andrieu, N., and Riou, G. Strong association between c-myb and estrogen-receptor expression in human breast cancer. Oncogene, 5: 131-135, 1990.